Health Care, Human Resources, and Manufacturing

Contract research company names VP of operations

December 23, 2016
Print
Text Size:
A A
Susan Buckham
Susan Buckham. Courtesy MPI Research

A former Pfizer executive with more than 30 years of life sciences experience is the new operational head at a contract research company in the region.

Mattawan-based MPI Research said last month it has named Susan Buckham as its VP of operations.

Buckham is responsible for the strategic leadership and direction of operations, coordinating and executing in-vivo studies. She will also allocate resources for growth and profitability.

“Susan’s industry knowledge and experience in strategic planning and leadership make her an exceptional asset to our organization,” said Rob DeWit, president and CEO, MPI Research. “Our employees and sponsors alike will benefit from her ability to identify organizational and process improvements to increase efficiencies and productivity at MPI Research.”

Buckham’s background

Most recently, Buckham was executive director of the Battle Creek Area Math and Science Center.

Previously, she has served as director of analytical services for Pfizer, where she was the team lead for the creation and operations of two GLP drug safety formulation and analytical labs in Kalamazoo and Sandwich, U.K. Buckham also spent time as site head for Covance, leading the build out and operations of an ISO 17025 food safety testing lab in Battle Creek.

Buckham has won the Covance Way Award for Excellence in Leading Advancements of People, Process and Clients and the Pfizer Global Research and Development Individual Achievement Award.

She holds an M.S. from Michigan State University and a B.S. from Wilmington College of Ohio.

MPI Research

MPI Research provides safety evaluation, discovery, bio-analytical, analytical and phase I clinical services to the medical and chemical industries.

MPI also offers imaging solutions, including pre-clinical and clinical imaging, radiochemistry and data analysis.

Recent Articles by Jesse O'Brien

Editor's Picks

Comments powered by Disqus